Full Paper
Compound 10asyn
:
Compound 10canti:
1H NMR (400 MHz, CDCl3): d=7.20–7.40 (m, 7H), 7.10–7.20 (m, 3H),
4.51 (br, 1H), 3.75 (br, 1H), 2.82 (m, 1H), 2.61 (m, 1H), 1.70 (m, 1H),
1.59 ppm (m, 1H).
1H NMR (400 MHz, CDCl3): d=7.88 (d, J=7.6 Hz, 1H), 7.65 (d, J=
7.6 Hz, 1H), 7.58 (dd, J=7.6, 7.6 Hz, 1H), 7.41 (dd, J=7.6, 7.6 Hz,
1H), 7.26 (dd, J=7.2, 7.2 Hz, 2H), 7.17 (t, J=7.2 Hz, 1H), 7.15 (d,
J=7.2 Hz, 2H), 5.14 (s, 1H), 3.96 (m, 1H), 2.86 (m, 1H), 2.60 (m,
1H), 2.41 (d, J=3.2 Hz, 1H), 1.95 (d, J=5.6 Hz, 1H), 1.80 (m, 1H),
1.74 ppm (m, 1H); 13C NMR (100 MHz, CDCl3): d=141.97, 139.54,
132.26, 129.09, 128.55, 128.52, 128.15 (q, J=29.6 Hz), 128.06,
126.01, 125.91 (q, J=5.7 Hz), 124.46 (q, J=272.7 Hz), 74.18, 72.34,
Compound 10aanti
:
1H NMR (400 MHz, CDCl3): d=7.20–7.40 (m, 7H), 7.10–7.20 (m, 3H),
4.69 (dd, J=3.2, 3.2 Hz, 1H), 3.86 (m, 1H), 2.83 (m, 1H), 2.64 (m,
1H), 2.28 (d, J=3.2 Hz, 1H), 1.87 (d, J=5.2 Hz, 1H), 1.77 (m, 1H),
1.61 ppm (m, 1H); 13C NMR (100 MHz, CDCl3): d=142.02, 140.38,
128.60ꢁ2, 128.51, 128.12, 126.94, 125.98, 77.27, 74.57, 33.48,
32.22 ppm; IR (KBr): n˜ =3343, 3251, 2934, 1452, 699 cmÀ1; HRMS
(FAB): calcd for C16H17O2: 241.1234 [MÀH]À; found: 241.1232.
32.82, 32.21 ppm; IR (KBr): n˜ =3323, 2957, 1312, 1162, 1117 cmÀ1
;
HRMS (FAB): calcd for C17H16F3O2: 309.1108 [MÀH]À; found:
309.1101.
General procedure for the formation of the acetonide 15 of
1,2-diol 10anti
:
Compound 10anti, 10-camphorsulfonic acid (10 mol%), MS3A (23 g),
and 2,2-dimethoxypropane (300 mol%) were added to dichlorome-
thane (15 mL) at RT under argon. The reaction mixture was stirred
for 1 h, then saturated aqueous NaHCO3 was added. MS3A was re-
moved from the reaction mixture by filtration and the aqueous
layer was extracted twice with dichloromethane. The combined or-
ganic layer was washed with brine, dried over MgSO4, and evapo-
rated. The residue was purified by silica-gel column chromatogra-
phy (hexane/ethyl acetate=1:0 to 8:1) to give 15.
1-(2-Fluorophenyl)-4-phenylbutane-1,2-diol (10b):
According to general procedure for the intermolecular cross-pina-
col coupling reaction, 3-phenylpropanal (8a) and 2-fluorobenzalde-
hyde were reductively coupled to give 10b (81%).
Compound 10bsyn
:
1H NMR (400 MHz, CDCl3): d=7.42 (dd, J=7.6, 7.6 Hz, 1H), 7.20–
7.30 (m, 3H), 7.10–7.20 (m, 4H), 7.03 (m, 1H), 4.87 (dd, J=4.8,
4.8 Hz, 1H), 3.79 (m, 1H), 2.81 (m, 1H), 2.64 (m, 1H), 2.57 (d, J=
4.8 Hz, 1H), 2.33 (d, J=4.8 Hz, 1H), 1.60–1.80 ppm (m, 2H).
2,2-Dimethyl-4-phenethyl-5-phenyl-1,3-dioxolane (15a):
According to the general procedure for the formation of the aceto-
nide 15 of 1,2-diol, 10aanti (77.2 mg, 0.319 mmol) was converted
into 15a (64.5 mg, 0.228 mmol, 71%). 1H NMR (400 MHz, CDCl3):
d=7.20–7.40 (m, 7H), 7.14 (dd, J=7.2, 7.2 Hz, 1H), 7.02 (d, J=
7.2 Hz, 2H), 5.19 (d, J=6.8 Hz, 1H), 4.35 (m, 1H), 2.64 (m, 1H), 2.44
(m, 1H), 1.66 (s, 3H), 1.46 (s, 3H), 1.45 (m, 1H), 1.23 ppm (m, 1H);
13C NMR (100 MHz, CDCl3): d=141.92, 137.97, 128.61, 128.41,
128.34, 127.90, 127.09, 125.90, 108.35, 80.10, 78.26, 33.53, 32.43,
Compound 10banti
:
1H NMR (400 MHz, CDCl3): d=7.53 (ddd, J=7.6, 7.6, 2.0 Hz, 1H),
7.20–7.30 (m, 3H), 7.10–7.20 (m, 4H), 7.02 (ddd, J=9.2, 7.6, 1.2 Hz,
1H), 5.09 (dd, J=4.4, 4.4 Hz, 1H), 3.97 (m, 1H), 2.81 (m, 1H), 2.64
(m, 1H), 2.38 (d, J=4.4 Hz, 1H), 1.92 (d, J=5.6 Hz, 1H), 1.74 (m,
1H), 1.58 ppm (m, 1H); 13C NMR (100 MHz, CDCl3): d=160.03 (d,
J=244.1 Hz), 141.92, 129.40 (d, J=8.6 Hz), 128.58, 128.55 (d, J=
5.7 Hz), 128.52, 127.30 (d, J=13.3 Hz), 126.02, 124.44 (d, J=2.9 Hz),
115.34 (d, J=21.9 Hz), 73.79, 70.91, 33.06, 32.20 ppm; IR (KBr): n˜ =
3369, 3253, 2936, 1454, 1101, 1064 cmÀ1; HRMS (FAB): calcd for
C16H16FO2: 259.1140 [MÀH]À; found: 259.1135.
27.79, 25.36 ppm; IR (KBr): n˜ =3066, 3031, 1700, 1288, 702 cmÀ1
;
HRMS (EI): calcd for C19H23O2: 283.1693 [M+H]+; found: 283.1696.
4-(2-Fluorophenyl)-2,2-dimethyl-5-phenethyl-1,3-dioxolane
(15b):
According to the general procedure for the formation of the aceto-
nide 15 of 1,2-diol, 10banti (16.3 mg, 0.0626 mmol) was converted
1
4-Phenyl-1-(2-(trifluoromethyl)phenyl)butane-1,2-diol (10c):
into 15b (10.2 mg, 0.0340 mmol, 54%). H NMR (400 MHz, CDCl3):
d=7.52 (dd, J=7.2, 7.2 Hz, 1H), 7.20–7.30 (m, 3H), 7.10–7.20 (m,
2H), 7.04 (d, J=7.2 Hz, 2H), 7.00 (m, 1H), 5.50 (d, J=6.8 Hz, 1H),
4.46 (m, 1H), 2.68 (m, 1H), 2.49 (m, 1H), 1.66 (s, 3H), 1.49 (s, 3H),
1.42 (m, 1H), 1.31 ppm (m, 1H); 13C NMR (100 MHz, CDCl3): d=
159.86 (d, J=244.0 Hz), 141.92, 129.18 (d, J=7.6 Hz), 128.58,
128.29, 128.28 (d, J=3.8 Hz), 125.90, 125.44 (d, J=13.4 Hz), 124.23
(d, J=2.9 Hz), 114.97 (d, J=21.0 Hz), 108.33, 77.58, 73.94 (d, J=
3.8 Hz), 33.39, 32.37, 27.81, 25.38 ppm; IR (KBr): n˜ =2958, 2930,
1728, 1261, 1057 cmÀ1; HRMS (EI): calcd for C19H22FO2: 301.1598
[M+H]+; found: 301.1607.
According to general procedure for the intermolecular cross-pina-
col coupling reaction, 3-phenylpropanal (8a) and 2-(trifluorometh-
yl)-benzaldehyde were reductively coupled to give 10c (70%).
Compound 10csyn
:
1H NMR (400 MHz, CDCl3): d=7.65 (d, J=7.6 Hz, 1H), 7.62 (d, J=
7.6 Hz, 1H), 7.56 (dd, J=7.6, 7.6 Hz, 1H), 7.40 (dd, J=7.6, 7.6 Hz,
1H), 7.25 (dd, J=7.2, 7.2 Hz, 2H), 7.16 (t, J=7.2 Hz, 1H), 7.11 (d, J=
7.2 Hz, 2H), 4.96 (dd, J=4.4, 4.4 Hz, 1H), 3.78 (m, 1H), 2.84 (m, 1H),
2.69 (d, J=4.4 Hz, 1H), 2.63 (m, 1H), 2.37 (d, J=4.4 Hz, 1H), 1.84
(m, 1H), 1.60 ppm (m, 1H); 13C NMR (100 MHz, CDCl3): d=141.63,
140.32, 132.33, 128.49ꢁ2, 128.44, 128.10, 127.93 (q, J=29.5 Hz),
126.02, 125.91 (q, J=5.7 Hz), 124.38 (q, J=272.7 Hz), 74.86, 72.39,
2,2-Dimethyl-4-phenethyl-5-(2-(trifluoromethyl)phenyl)-1,3-
dioxolane (15c):
According to the general procedure for the formation of the aceto-
nide 15 of 1,2-diol, 10canti (21.7 mg, 0.070 mmol) was converted
into 15c (4.4 mg, 0.0126 mmol, 18%). 1H NMR (400 MHz, CDCl3):
d=7.78 (d, J=7.6 Hz, 1H), 7.62 (d, J=7.6 Hz, 1H), 7.55 (dd, J=7.6,
34.58, 32.11 ppm; IR (KBr): n˜ =3245, 2949, 1310, 1167, 1121 cmÀ1
;
HRMS (FAB): calcd for C17H16F3O2: 309.1108 [MÀH]À; found:
309.1105.
Chem. Eur. J. 2014, 20, 1615 – 1621
1620
ꢀ 2014 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim